New Pharmaceutical Product

Genus PLC 15 December 2004 For Immediate Release 15 December 2004 Genus plc New Pharmaceutical Product Genus plc ('Genus') the Global bovine genetics company has concluded negotiation for a new veterinary product for its veterinary sales and marketing business, Animalcare. The agreement is with a large European based pharmaceutical supplier and gives Animalcare the right to develop and register a generic version of an established companion animal medicine in the UK and certain other countries in the EU. Animalcare expects, at product maturity, to gain a significant share of the market for this product which is currently around £5m p.a. in the UK alone. Richard Wood, Chief Executive of Genus, commented: 'I am delighted to announce this important development which confirms that Animalcare is making good progress in its acquisition of high value pharmaceutical products to extend its range.' Contact: Richard Wood, Chief Executive Tel: 01256 347101 David Timmins, Finance Director Tel: 01256 347102 Charles Ryland/Suzanne Brocks Tel: 020 7466 5000 Buchanan Communications This information is provided by RNS The company news service from the London Stock Exchange